Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE

Journal of Infectious Diseases  15 Apr 2008  V.197  N.8  p.1079–1081

EDITORIAL COMMENTARY

Louis B. Rice

Louis Stokes Cleveland VA Medical Center and Case Western Reserve University, Cleveland, Ohio

FREE Full Text (CLIC en PDF version)
http://www.journals.uchicago.edu/doi/full/10.1086/533452

It’s Time for a Change in Practice: Reducing Antibiotic Use Can Alter Antibiotic Resistance

Journal of Infectious Diseases  15 Apr 2008  V.197  N.8  p.1082–1083

EDITORIAL COMMENTARY

Cindy R. Friedman and Cynthia G. Whitney

Centers for Disease Control and Prevention, Atlanta, Georgia

FREE Full Text (CLIC en PDF version)
http://www.journals.uchicago.edu/doi/full/10.1086/533450

The Search for Data on When to Start Treatment for HIV Infection

Journal of Infectious Diseases  15 Apr 2008  V.197  N.8  p.1084–1086

EDITORIAL COMMENTARY

Michael D. Hughes and Heather R. Ribaudo

Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts

FREE Full Text (CLIC en PDF version)
http://www.journals.uchicago.edu/doi/full/10.1086/586712

The Research Agenda of the National Institute of Allergy and Infectious Diseases for Antimicrobial Resistance

Journal of Infectious Diseases  15 Apr 2008  V.197  N.8  p.1087–1093

PERSPECTIVE

N. Kent Peters, Dennis M. Dixon, Steven M. Holland, and Anthony S. Fauci

National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

FREE Full Text (CLIC en PDF version)
http://www.journals.uchicago.edu/doi/abs/10.1086/533451

Seasonality of Antibiotic-Resistant Streptococcus pneumoniae That Causes Acute Otitis Media: A Clue for an Antibiotic-Restriction Policy?

Journal of Infectious Diseases  15 Apr 2008  V.197  N.8  p.1094–1102

Ron Dagan,1 Galia Barkai,1 Noga Givon-Lavi,1 Amir Z. Sharf,2 Daniel Vardy,2 Ted Cohen,3,4 Marc Lipsitch,3 and David Greenberg1

1Pediatric Infectious Disease Unit, Soroka University Medical Center, and the Faculty of Health Sciences, Ben-Gurion University of the Negev, and 2Israel General Health Insurance Plan, Beer-Sheva, Israel; 3Department of Epidemiology, Harvard School of Public Health, and 4Division of Social Medicine and Health Inequalities, Brigham and Women’s Hospital, Boston, Massachusetts

FREE Full Text (CLIC en PDF version)
http://www.journals.uchicago.edu/doi/abs/10.1086/528995

 

Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and in Those Not Receiving ART at Baseline in the SMART Study

Journal of Infectious Diseases  15 Apr 2008  V.197  N.8  p.1133-1144

The Strategies for Management of Antiretroviral Therapy (SMART) Study Group a

FREE Full Text (CLIC en PDF version)
http://www.journals.uchicago.edu/doi/abs/10.1086/586713

Infection control measures to limit the spread of Clostridium difficile

Clinical Microbiology and Infection  May 2008  V.14  S5  p.2-20

R.-P. Vonberg11Institute for Medical Microbiology and Hospital Epidemiology, Medical School Hannover, Hannover, Germany, E. J. Kuijper22Leiden University Medical Centre, Leiden, The Netherlands, M. H. Wilcox33Department of Microbiology, Leeds Teaching Hospitals and University of Leeds, Leeds, UK, F. Barbut44Unité d’Hygiène et de Lutte contre les Infections Nosocomiales, Hôpital Saint-Antoine, Paris, France, P. Tüll55European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden, P. Gastmeier11Institute for Medical Microbiology and Hospital Epidemiology, Medical School Hannover, Hannover, Germany, on behalf of the European C. difficile-Infection Control Group and the European Centre for Disease Prevention and Control (ECDC), P. J. van den Broek22Leiden University Medical Centre, Leiden, The Netherlands, A. Colville66Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK, B. Coignard77Institut de Veille Sanitaire, Saint-Maurice, France, T. Daha88The Dutch Working Party Infection Control, Leiden, S. Debast99Meander Medical Centre, Amersfoort, The Netherlands, B. I. Duerden1010Department of Health, London, UK, S. van den Hof1111Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands, T. van der Kooi1111Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands, H. J. H. Maarleveld22Leiden University Medical Centre, Leiden, The Netherlands, E. Nagy1212Institute of Clinical Microbiology, Faculty of Medicine, University of Szeged, Szeged, Hungary, D. W. Notermans1111Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands, J. O’Driscoll1313Stoke Mandeville Hospital, Stoke Mandeville, Buckinghamshire, UK, B. Patel1414Health Protection Agency, London, UK, S. Stone1515Academic Department of Geriatric Medicine, Hampstead Campus, Royal Free and University College Medical School, London, UK and C. Wiuff1616Health Protection Scotland, Glasgow, UK1Institute for Medical Microbiology and Hospital Epidemiology, Medical School Hannover, Hannover, Germany, 2Leiden University Medical Centre, Leiden, The Netherlands, 3Department of Microbiology, Leeds Teaching Hospitals and University of Leeds, Leeds, UK, 4Unité d’Hygiène et de Lutte contre les Infections Nosocomiales, Hôpital Saint-Antoine, Paris, France, 5European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden, 6Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK, 7Institut de Veille Sanitaire, Saint-Maurice, France, 8The Dutch Working Party Infection Control, Leiden, 9Meander Medical Centre, Amersfoort, The Netherlands, 10Department of Health, London, UK, 11Centre for Infectious Disease Control Netherlands, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands, 12Institute of Clinical Microbiology, Faculty of Medicine, University of Szeged, Szeged, Hungary, 13Stoke Mandeville Hospital, Stoke Mandeville, Buckinghamshire, UK, 14Health Protection Agency, London, UK, 15Academic Department of Geriatric Medicine, Hampstead Campus, Royal Free and University College Medical School, London, UK and 16Health Protection Scotland, Glasgow, UK

abstract
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2008.01992.x

Adjunctive Use of Rifampin for the Treatment of Staphylococcus aureus Infections

Archives of Internal Medicine  28 Apr 2008  V.168  N.8  p.805-819

A Systematic Review of the Literature

Division of Infectious Diseases (Drs Perlroth, Bayer, and Miller) and Los Angeles Biomedical Research Institute (Ms Tan and Dr Miller), Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, St Mary Medical Center, Long Beach (Dr Kuo), and Division of Infectious Diseases, David Geffen School of Medicine at the University of California, Los Angeles (Drs Bayer and Miller). Dr Kuo is now with Division of Infectious Diseases, Department of Medicine, University of California, Irvine.

abstract
http://archinte.ama-assn.org/cgi/content/abstract/168/8/805

Risk Factors for Sporadic Shiga Toxin–producing Escherichia coli Infections in Children, Argentina1

EID, Apr. 2008  V.14  N.5 

Marta Rivas,* Sergio Sosa-Estani,† Josefa Rangel,‡ Maria G. Caletti,§ Patricia Vallés,¶ Carlos D. Roldán,§ Laura Balbi,¶ Maria C. Marsano de Mollar,# Diego Amoedo,§ Elizabeth Miliwebsky,* Isabel Chinen,* Robert M. Hoekstra,‡ Paul Mead,‡ and Patricia M. Griffin‡

*Instituto Nacional de Enfermedades Infecciosas, Buenos Aires, Argentina; †Centro Nacional de Endemoepidemias, Buenos Aires, Argentina; ‡Centers for Disease Control and Prevention, Atlanta, Georgia, USA; §Hospital Nacional de Pediatría, Buenos Aires, Argentina; ¶Hospital Pediátrico, Mendoza, Argentina; and #Ministerio de Desarrollo Social y Salud, Mendoza, Argentina

FREE Full Text (CLIC en Download this article as PDF)
http://www.cdc.gov/eid/content/14/5/763.htm

 

Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients

Antimicrobial Agents and Chemotherapy  1 May 2008  V.52  N.5  p.1743-1750

Peter Troke,1* Koldo Aguirrebengoa,2 Carmen Arteaga,3 David Ellis,4 Christopher H. Heath,5 Irja Lutsar,6

Montserrat Rovira,7 Quoc Nguyen,8 Monica Slavin,9 Sharon C. A. Chen,10 on behalf of the Global Scedosporium Study Group The Old Court, Broadstairs, Kent, United Kingdom,1 Hospital de Cruces, Baracaldo Vizcaya, Spain,2 Pfizer Inc., New York, New York,3 Women’s and Children’s Hospital, Adelaide, Australia,4 Royal Perth Hospital, Perth, Australia,5 University of Tartu, Tartu, Estonia,6 Hematology Hospital Clinic, Barcelona, Spain,7 St. Vincent’s Hospital, Sydney, Australia,8 Peter MacCallum Cancer Centre, Melbourne, Australia,9 Westmead Hospital, Sydney, Australia,10

abstract
http://aac.asm.org/cgi/content/abstract/52/5/1743